Cardlytics Stock Analysis
CDLX Stock | USD 1.78 0.01 0.56% |
Cardlytics is undervalued with Real Value of 2.19 and Target Price of 2.9. The main objective of Cardlytics stock analysis is to determine its intrinsic value, which is an estimate of what Cardlytics is worth, separate from its market price. There are two main types of Cardlytics' stock analysis: fundamental analysis and technical analysis.
The Cardlytics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Cardlytics is usually not traded on National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Cardlytics Stock trading window is adjusted to America/New York timezone.
Cardlytics | Build AI portfolio with Cardlytics Stock |
Cardlytics Stock Analysis Notes
About 55.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.48. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cardlytics recorded a loss per share of 3.57. The entity had not issued any dividends in recent years. Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Cardlytics operates under Advertising Agencies classification in the United States and is traded on NASDAQ Exchange. It employs 710 people. For more info on Cardlytics please contact Karim Temsamani at 888 798 5802 or go to https://www.cardlytics.com.Cardlytics Quarterly Total Revenue |
|
Cardlytics Investment Alerts
Cardlytics is way too risky over 90 days horizon | |
Cardlytics may become a speculative penny stock | |
Cardlytics appears to be risky and price may revert if volatility continues | |
Cardlytics has high likelihood to experience some financial distress in the next 2 years | |
Cardlytics currently holds 221.65 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardlytics' use of debt, we should always consider it together with its cash and equity. | |
The entity reported the previous year's revenue of 278.3 M. Net Loss for the year was (189.3 M) with profit before overhead, payroll, taxes, and interest of 115.16 M. | |
Cardlytics currently holds about 157.04 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Cardlytics has a frail financial position based on the latest SEC disclosures | |
Latest headline from news.google.com: Cardlytics amends agreement with JPMorgan Chase, extends term to 2028 By Investing.com - Investing.com Canada |
Cardlytics Upcoming and Recent Events
Earnings reports are used by Cardlytics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
6th of March 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Cardlytics Largest EPS Surprises
Earnings surprises can significantly impact Cardlytics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-08-07 | 2024-06-30 | -0.13 | -0.15 | -0.02 | 15 | ||
2024-05-08 | 2024-03-31 | -0.11 | -0.09 | 0.02 | 18 | ||
2024-03-14 | 2023-12-31 | 0.12 | 0.14 | 0.02 | 16 |
Cardlytics Stock Institutional Investors
Shares | Millennium Management Llc | 2025-03-31 | 705.6 K | Lane Generational Llc | 2025-03-31 | 609.6 K | Dimensional Fund Advisors, Inc. | 2025-03-31 | 429.6 K | Landscape Capital Management,llc | 2025-03-31 | 400 K | Northern Trust Corp | 2025-03-31 | 365.7 K | Charles Schwab Investment Management Inc | 2025-03-31 | 340.7 K | Acorn Financial Advisory Services Inc | 2025-03-31 | 337.4 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 289.6 K | Citigroup Inc | 2025-03-31 | 280.2 K | Blackrock Inc | 2025-03-31 | 3.1 M | Vanguard Group Inc | 2025-03-31 | 2.7 M |
Cardlytics Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 95.03 M.Cardlytics Profitablity
The company has Profit Margin (PM) of (0.65) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.31.Management Efficiency
Cardlytics has return on total asset (ROA) of (0.0878) % which means that it has lost $0.0878 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3548) %, meaning that it created substantial loss on money invested by shareholders. Cardlytics' management efficiency ratios could be used to measure how well Cardlytics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cardlytics' Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 190.9 M in 2025, whereas Other Assets are likely to drop slightly above 2.2 M in 2025.The decision-making processes within Cardlytics are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Technical Drivers
As of the 9th of July, Cardlytics shows the Downside Deviation of 6.37, mean deviation of 5.12, and Risk Adjusted Performance of 0.0588. Cardlytics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Cardlytics Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Weighted Moving Average calculates a weight for each value in Cardlytics price series with the more recent values given greater weights.
Cardlytics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cardlytics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cardlytics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cardlytics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cardlytics Outstanding Bonds
Cardlytics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cardlytics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cardlytics bonds can be classified according to their maturity, which is the date when Cardlytics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
US14162VAB27 Corp BondUS14162VAB27 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
Cardlytics Predictive Daily Indicators
Cardlytics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cardlytics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Cardlytics Forecast Models
Cardlytics' time-series forecasting models are one of many Cardlytics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cardlytics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Cardlytics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Cardlytics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cardlytics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cardlytics. By using and applying Cardlytics Stock analysis, traders can create a robust methodology for identifying Cardlytics entry and exit points for their positions.
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Cardlytics operates under Advertising Agencies classification in the United States and is traded on NASDAQ Exchange. It employs 710 people.
Current Cardlytics Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cardlytics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cardlytics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
2.9 | Hold | 6 | Odds |
Most Cardlytics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cardlytics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cardlytics, talking to its executives and customers, or listening to Cardlytics conference calls.
Cardlytics Stock Analysis Indicators
Cardlytics stock analysis indicators help investors evaluate how Cardlytics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cardlytics shares will generate the highest return on investment. By understating and applying Cardlytics stock analysis, traders can identify Cardlytics position entry and exit signals to maximize returns.
Begin Period Cash Flow | 91.8 M | |
Long Term Debt | 167.7 M | |
Common Stock Shares Outstanding | 48.4 M | |
Total Stockholder Equity | 70 M | |
Quarterly Earnings Growth Y O Y | -0.567 | |
Property Plant And Equipment Net | 8.9 M | |
Cash And Short Term Investments | 65.6 M | |
Cash | 65.6 M | |
Accounts Payable | 3.7 M | |
Net Debt | 156.1 M | |
50 Day M A | 1.803 | |
Total Current Liabilities | 149 M | |
Other Operating Expenses | 473.8 M | |
Non Current Assets Total | 214.7 M | |
Non Currrent Assets Other | 35 M | |
Stock Based Compensation | 40.4 M |
Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.